Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. IGC Pharma Inc. (IGC) Message Board

420 with CNW — Schumer Promises to Fight for Fed

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 436
(Total Views: 164)
Posted On: 01/05/2023 4:33:16 PM
Avatar
Posted By: NetworkNewsWire
420 with CNW — Schumer Promises to Fight for Federal Cannabis Decriminalization in 2023

After reformers encountered several defeats in December, Senate Majority Leader Chuck Schumer has pledged to continue working toward decriminalizing marijuana on a federal level next year. Schumer gave a speech in the Senate in which he praised the efforts of Reggie Babin, a senior staffer who has been leading the charge for marijuana policy reform legislation. He promised to carry on with Babin’s work and legacy, mentioning a few things that Babin had wished to accomplish, such as aiding in the decriminalization of marijuana.

Even though Schumer, Senator Cory Booker (D-NJ) and Senator Ron Wyden produced a comprehensive cannabis legalization measure in July, analysts say it was obvious that the extensive legislation lacked the support necessary to pass the Senate with 60 votes.

Due to this, Schumer has moved to complete a set of more modest reforms, with the banking and decriminalization of cannabis as their focal points. Advocates had anticipated that the reform would be tacked onto important defense or funding bills that were required to advance before the session ended. However, that did not occur, largely because backers ran into opposition from Senate Minority leader Mitch McConnell (R-KY) and other Republicans.

In late December, Representative Ed Perlmutter, a Democrat from Colorado and the lead sponsor of SAFE Banking, tabled an amendment modifying the omnibus spending bill to incorporate the reforms. However, Perlmutter didn’t compel putting the matter to a vote; it was mostly made as a show of support prior to his resignation from Congress.

A Senate insider recently said that Schumer was attempting to incorporate the marijuana banking language into the country’s spending bill at the last minute but was unable to come to an agreement. He said the issue would have to wait until the new Congress takes office, in which the House will be under Republican control.

Obviously, discussions about including new provisions in the bill were delicate, and reform on drug policy suffered as a result until a final consensus position was reached. Along with not mentioning SAFE Plus or SAFE Banking, the law also excluded a number of other reform ideas that were added to budget bills which were previously enacted by the Senate and House.

Another significant defeat for proponents is that this bill keeps a clause that bars the country’s capital from setting up a controlled cannabis trade system.

Sherrod Brown, the chair of Senate’s Banking Committee, indicated that there’s a high chance cannabis banking would come up in 2023. Nevertheless, a staff member said early in December that he would still be open to including it in the spending bill if it contained more comprehensive provisions.

The Financial Services Committee head in the upcoming Congress, Representative Patrick McHenry (R-NC), has stated that he agrees that the matter should be handled after the “lame duck” is over. Although the congressman declared that he continues to oppose SAFE Banking, he left the door open to backing it on condition that his Republican colleagues embrace it too.

The goings on in the upcoming Congress are likely to be of key interest to companies such as India Globalization Capital Inc. (NYSE America: IGC) because any policy changes could have a profound impact upon the trajectory of the marijuana industry.

NOTE TO INVESTORS: The latest news and updates relating to India Globalization Capital Inc. (NYSE American: IGC) are available in the company’s newsroom at https://cnw.fm/IGC

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer




(0)
(0)




IGC Pharma Inc. (IGC) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us